Connaught Mycobax indications follow ACET/ACIP guidelines for TB prevention in high-risk groups.
Executive Summary
CONNAUGHT MYCOBAX PROPOSED TB INDICATIONS FOLLOW ACET/ACIP RECOMMENDATIONS for use of the Bacillus Calmette-Guerin vaccine to treat populations at high risk of developing tuberculosis. The Advisory Committee on Elimination of Tuberculosis and the Advisory Committee on Immunization Practices joint recommendations will be published in an upcoming Center for Disease Control & Prevention Morbidity & Mortality Weekly Report.